Kura Oncology
KURA
107 hedge funds and large institutions have $541M invested in Kura Oncology in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 12 closing their positions.
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
33% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 30
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
22% more capital invested
Capital invested by funds: $442M → $541M (+$98.8M)
17.9% more ownership
Funds ownership: 70.68% → 88.57% (+18%)
9% more funds holding
Funds holding: 98 → 107 (+9)
92% less call options, than puts
Call options by funds: $198K | Put options by funds: $2.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$25.2M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$23.2M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$15.7M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$11.9M |
| 5 |
BlackRock
New York
|
+$6.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.1M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.27M |
| 3 |
AG
Artal Group
Luxembourg
|
-$1.88M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.47M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$992K |
KURA Hedge Fund Activity: Q2 2018 in Review
107 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2018, worth a combined $541M — up 22% from $442M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new KURA positions and 12 closed out — a net gain of 10 holders — while 40 added to existing stakes and 30 trimmed.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $25.2M. The largest seller was Fidelity Investments, cutting an estimated $18.1M.
- 107 institutional investors held Kura Oncology (KURA) as of Q2 2018, up from 98 in Q1 2018.
- Funds reported $541M of Kura Oncology stock for Q2 2018, up 22% quarter-over-quarter.
- 22 funds opened new Kura Oncology positions in Q2 2018 and 12 closed out, a net change of +10 holders.
- The largest Kura Oncology buyer in Q2 2018 was Victory Capital Management, an estimated $25.2M added.
- The largest Kura Oncology seller in Q2 2018 was Fidelity Investments, an estimated $18.1M sold.
Based on aggregated 13F filings for Q2 2018.